Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C60 - Clinical Pearls in Autoimmune Neurology: Real-world Cases

Sunday 04/14/24
03:30 PM - 05:30 PM MDT Add To Calendar
Colorado Convention Center | Mile High 2/3
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Sarosh R Irani, MD, PhD, FRCP FEAN
Autoimmune Neurology
Participants should be able to recognize and become familiar with case-based descriptions of some of neurology's most treatable autoimmune conditions, spanning the breadth of demyelination, encephalitis, and peripheral neuropathies; recall and interpret investigation features which lead to, and divert from, an accurate autoimmune diagnosis including conditions with antibodies against AQP4, MOG, NMDAR, LGI1, CASPR2, Iglon5, Contactin-1 and NF-155.; and formulate and appraise management plans for these patients.
2.00 CME credits
Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement
Intermediate
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials

Event Timeline
03:30 PM - 04:10 PM MDT Speaker Treatable Causes of Seizures, Encephalitis, and Movement Disorders
Sarosh R Irani, MD, PhD, FRCP FEAN
04:10 PM - 04:50 PM MDT Speaker Pitfalls and Pearls in Diagnosing Treatable Forms of Demyelination
Brian G. Weinshenker, MD, FAAN
04:50 PM - 05:30 PM MDT Speaker Treating the Nerve, Muscle and its Junction: Case-based Discussions
Christopher Lamb, MD
Faculty Disclosures
Sarosh R Irani, MD, PhD, FRCP FEAN Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB, Cerebral therapeutics, Roche and Janssen. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. The institution of Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a speaker at internal meeting and symposium with Horizon.
Christopher Lamb, MD Dr. Lamb has received research support from Immunovant, Inc.